.Only five months after protecting a $one hundred million IPO, Limitless Bio is currently giving up ...
.The preliminary stages of oncology R&D may not be short of fascinating brand-new modalities, as ...
.Psychopharmacology has drawn three posts concerning midstage professional test data evaluating Lyko...
.Avidity Biosciences amazed investors with stage 1/2 data in Duchenne muscular dystrophy (DMD) Frida...
.Actinogen Medical's cortisol blocker has overlooked the major endpoint of a phase 2 research in dep...
.Antibody-drug conjugates (ADCs) have actually been at the facility of many a billion-dollar biobuck...
.Property supervisor TPG, which has actually sustained biotechs including Sionna Therapies and Santa...
.Merck & Co.'s TIGIT course has endured yet another trouble. Months after shuttering a period 3 c...
.After a year specified through pipeline cuts, the variation of its CEO as well as unemployments, Ex...
.Cullinan Rehab was impressed sufficient with Port BioMed's bispecific immune system activator that ...